Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients - 14/05/24
Doi : 10.1016/j.jaad.2023.12.074
Heather A. Brandling-Bennett, MD a, b, ⁎ 
, Lisa M. Arkin, MD c, Yvonne E. Chiu, MD d, Adelaide A. Hebert, MD e, Jeffrey P. Callen, MD f, Leslie Castelo-Soccio, MD g, Dominic O. Co, MD c, Kelly M. Cordoro, MD h, Megan L. Curran, MD i, Austin M. Dalrymple, MD j, k, Carsten Flohr, MD l, Ken B. Gordon, MD d, Diane Hanna, DNP m, Alan D. Irvine, MD n, Susan Kim, MD h, A. Yasmine Kirkorian, MD o, p, Irene Lara-Corrales, MD q, Jill Lindstrom, MD r, Amy S. Paller, MD s, Melissa Reyes, MD t, Wendy Smith Begolka, MBS u, Wynnis L. Tom, MD v, w, Abby S. Van Voorhees, MD x, Ruth Ann Vleugels, MD y, z, Lara Wine Lee, MD aa, Olivia Davies, MD d, Elaine C. Siegfried, MD j, k
, Lisa M. Arkin, MD c, Yvonne E. Chiu, MD d, Adelaide A. Hebert, MD e, Jeffrey P. Callen, MD f, Leslie Castelo-Soccio, MD g, Dominic O. Co, MD c, Kelly M. Cordoro, MD h, Megan L. Curran, MD i, Austin M. Dalrymple, MD j, k, Carsten Flohr, MD l, Ken B. Gordon, MD d, Diane Hanna, DNP m, Alan D. Irvine, MD n, Susan Kim, MD h, A. Yasmine Kirkorian, MD o, p, Irene Lara-Corrales, MD q, Jill Lindstrom, MD r, Amy S. Paller, MD s, Melissa Reyes, MD t, Wendy Smith Begolka, MBS u, Wynnis L. Tom, MD v, w, Abby S. Van Voorhees, MD x, Ruth Ann Vleugels, MD y, z, Lara Wine Lee, MD aa, Olivia Davies, MD d, Elaine C. Siegfried, MD j, k a Seattle Children's Hospital, Seattle, Washington
b Division of Dermatology, Department of Pediatrics, University of Washington, Seattle, Washington
c Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
d Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
e Department of Dermatology, UTHealth McGovern Medical School at Houston, Houston, Texas
f Department of Dermatology, University of Louisville School of Medicine, Louisville, Kentucky
g Dermatology Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland
h Department of Dermatology, University of California, San Francisco, San Francisco, California
i Division of Rheumatology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado
j Division of Rheumatology, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri
k SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri
l Department of Paediatric Dermatology, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust, London, UK
m Modern Dermatology, Shawnee, Kansas
n Department of Paediatric Dermatology, Trinity College Dublin, Dublin, Ireland
o Department of Dermatology, George Washington University School of Medicine & Health Sciences, Washington, District of Columbia
p Children's National Hospital, Washington, District of Columbia
q Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
r Walter Reed National Military Medical Center, Bethesda, Maryland
s Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
t Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland
u National Eczema Association, Novato, California
v Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, San Diego, California
w Rady Children's Hospital-San Diego, San Diego, California
x Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia
y Brigham and Women's Hospital, Boston, Massachusetts
z Department of Dermatology, Harvard Medical School, Boston, Massachusetts
aa Department of Dermatology, Medical University of South Carolina, Charleston, South Carolina
∗Correspondence to: Heather A. Brandling-Bennett, MD, Seattle Children's Hospital, 4800 Sand Point Way NE, M/S OC.9.835, Seattle, WA 98105Seattle Children's Hospital4800 Sand Point Way NEM/S OC.9.835SeattleWA98105
Key words : adolescent, child, consensus, guidelines, methotrexate, pediatric
| Funding sources: This work was supported by a generous grant from the Pediatric Dermatology Research Alliance (PeDRA), with additional funding from the National Eczema Association (NEA) and the National Psoriasis Foundation (NPF). Funding sources had no influence on the content of the guidelines beyond several authors being members of the funding sources and review and approval of the final document by the Pediatric Dermatology Research Alliance (PeDRA) Best Practices Task Force. |
|
| Disclaimer: This publication has been reviewed by FDA and determined not to be consistent with the Agency's views or policies. It reflects only the views and opinions of the authors. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 90 - N° 6
P. 1271-1275 - juin 2024 Retour au numéro
Article précédent
- Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
- Rachel M. Reardon, Katherine L. Perlman, Maria S. Asdourian, Nishi Shah, Ted V. Jacoby, Leah L. Thompson, Kerry L. Reynolds, Yevgeniy R. Semenov, Steven T. Chen
- Combined reflectance confocal microscopy and optical coherence tomography in the evaluation of cutaneous squamous cell carcinoma
- Abdullah Aleisa, Miguel Cordova, Catherine Payulert, Haifa Aldawood, Erica H. Lee, Kishwer S. Nehal, Anthony M. Rossi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?